Skip to main content
Premium Trial:

Request an Annual Quote

NCI Extends Synthetic Genetics Agreement with GeneArt for $1.9M

NEW YORK (GenomeWeb News) – The National Cancer Institute has renewed a contract agreement with GeneArt, under which the company already has developed over 3,500 synthetic genes for around $3.5 million, the company said Friday.
GeneArt said it has agreed to develop another 200 genes for NCI’s Mammalian Gene Collection Program for an additional $1.9 million.
The contract the company initially agreed to in January 2007 was assigned by the company SAIC-Frederick on behalf of NCI and would allow it to perform up to $6.5 million in gene synthesis services for the institute.
The MGC Program is a collection of human and mouse genes to be used for basic research and for clinical R&D.
Due to a large number of repetitive DNA sequence elements and toxic elements involved in the research, GeneArt said it had to “further advance its existing technologies and establish new production techniques.”
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.